Intervacc is trading at €0.08, down 8.8% today, as the thinly traded small-cap biotech experiences volatility-driven swings.
- There are no fresh company announcements, earnings reports, or regulatory updates pointing to a clear catalyst for the price action.
- The move appears to reflect normal noise in a highly volatile name, occurring despite a generally positive backdrop for the wider biotech sector.